# FDA Inspection 1257689 - Ruyuan Hec Pharm Co. Ltd. - November 22, 2024

Source: https://www.keypedia.com/records/fda_inspections/ruyuan-hec-pharm-co-ltd/d094c3ad-d7fa-471f-b927-cbe715bfd251
Source feed: FDA_Inspections

> FDA Inspection 1257689 for Ruyuan Hec Pharm Co. Ltd. on November 22, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1257689
- Company Name: Ruyuan Hec Pharm Co. Ltd.
- Inspection Date: 2024-11-22
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1257689 - 2024-11-22](https://www.keypedia.com/records/fda_inspections/ruyuan-hec-pharm-co-ltd/e8e7ce0d-3508-4278-9948-ae38274f7ef7)
- [FDA Inspection 1141911 - 2019-11-29](https://www.keypedia.com/records/fda_inspections/ruyuan-hec-pharm-co-ltd/f3d2f1b0-db9f-4c95-ae86-f2d93bebe66f)
- [FDA Inspection 944632 - 2015-09-11](https://www.keypedia.com/records/fda_inspections/ruyuan-hec-pharm-co-ltd/180a5c38-5947-49e5-83e4-811cacd8f541)

Company: https://www.keypedia.com/companies/ruyuan-hec-pharm-co-ltd/ca7e724b-be57-4260-8efe-13f53bd7c605

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c